52w high/low | ₹196.1 / ₹110 |
P/E ratio | 470.59 |
Dividend | 0 |
ROE | 0.91 |
ROCE | 3.18 |
Face value | 10 |
Book value | ₹34.98Cr |
Market capital | ₹189.25Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Bafna was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p. a. Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p. a. and then liquid line with an installed capacity of 45000 lts p. a was added in 1990.